Abstract
Background A systematic approach to collect, peruse and summarise the available information relating to the potential benefits of consuming dietary microbes was pursued in this scoping review. This review focused on the research endpoints, experimental designs, and microbial exposure in experimental as well as observational research work.
Approach Using a structured-set of keywords, scientific databases were systematically searched to retrieve publications reporting outcomes pertaining to the use of dietary-microbes in healthy, non-patient populations. Searches were further tailored to focus on eight different health categories, namely, “antibiotic associated diarrhoea” (AAD), “gastrointestinal health” (GIH), “immunological health” (ImH), “cardiovascular health and metabolic syndrome” (CvHMS), “cancer prevention” (CanPr), “respiratory health” (ReH), “weight management” (WtMgt), and “urogenital health” (UrGH). Quality of evidence available in each publication was assessed using the Jadad scoring system.
Result The search yielded 228 relevant publications describing 282 experimental cases comprising 62 research endpoints overall. A microbial dose of ≥2 × 109 CFU·day−1 was associated with non-negative reported outcomes. Older population groups with a median age of 39 years were associated with positive outcomes.
Conclusion More high-quality research is required investigating the role of dietary microbes in maintaining general health, particularly in the health categories of urogenital health, weight management and cancer prevention.
Competing Interest Statement
This work was supported by the Institute for the Advancement of Food and Nutrition Sciences (IAFNS). IAFNS is a nonprofit science organization that pools funding from industry and advances science through the in-kind and financial contributions from private and public sector members. Research in the Cotter laboratory is also funded by the European Union's Horizon 2020 research and innovation programme, under the MASTER project [grant number 818368], by Science Foundation Ireland (SFI) under [grant number SFI/12/RC/2273_P2] (APC Microbiome Ireland), by SFI together with the Irish Department of Agriculture, Food and the Marine under [grant number SFI/16/RC/3835] (VistaMilk) and by Enterprise Ireland and industry in the Food for Health Ireland (FHI)-3 project, under [grant number TC/2018/0025]. Other authors have no other conflicts to declare.
Funding Statement
This work was supported by the Institute for the Advancement of Food and Nutrition Sciences (IAFNS). IAFNS is a nonprofit science organization that pools funding from industry and advances science through the in-kind and financial contributions from private and public sector members. Research in the Cotter laboratory is also funded by the European Union's Horizon 2020 research and innovation programme, under the MASTER project [grant number 818368], by Science Foundation Ireland (SFI) under [grant number SFI/12/RC/2273_P2] (APC Microbiome Ireland), by SFI together with the Irish Department of Agriculture, Food and the Marine under [grant number SFI/16/RC/3835] (VistaMilk) and by Enterprise Ireland and industry in the Food for Health Ireland (FHI)-3 project, under [grant number TC/2018/0025]. Other authors have no other conflicts to declare.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Shared first author
1. Two of the author names were corrected by adding appropriate accents. 2. Since .csv files cannot be uploaded here, they have been converted to .tsv files. They have now been uploaded as well. 3. The manuscript noted the inclusion of a Supplementary_Materials.docx file. The file was rewritten in LaTeX and is now appended as a .pdf file. Also corresponding Supplementary Figures have been uploaded separately.
Data Availability
All data produced are available online at: https://osf.io/kvhe7/